Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Vishnu Chemicals share price today

VISHNUSpeciality chemicalConsolidatedPrices to 18 Nov 2026Results to Sep 2026

Price, 200-day average and NIFTY 500

The price is 6.7% below its 200-day average and 168 points ahead of the NIFTY 500 over 5 years

18 Nov 2026₹551.95Over 5 years: Vishnu Chemicals +224.1%, NIFTY 500 +55.7%
₹100₹500Nov 22Nov 24Nov 26

Price growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y+14.8%3Y+20.6%/yr5Y+26.5%/yr10Y+27.3%/yr

EPS and P/E

EPS ₹22.64, up 9% in a year; P/E 24.4

18 Nov 2026₹22.64 EPS
Dec 21
Mar 22
Jun 22
Sep 22
Dec 22
Mar 23
Jun 23
Sep 23
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
Nov 26
₹0₹30

EPS growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y+9.4%3Y+4.7%/yr5Y+25.9%/yr10Y+20.3%/yr

Revenue and margins

Revenue up on a year for 10 quarters in a row; operating margin 14.9%

Sep 2026 quarter₹430 crore+7.2% on ₹401 crore a year earlier · NPM 8.4%
Dec 21
Mar 22
Jun 22
Sep 22
Dec 22
Mar 23
Jun 23
Sep 23
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
0₹600

Revenue: 1Y change, then growth a year; margins are averages

Revenue growth1Y+14.0%3Y+10.7%/yr5Y+18.8%/yr to Mar10Y+12.9%/yr to Mar
OPM average3Y15.8%5Y15.9% to Mar
NPM average3Y8.7%5Y8.7% to Mar

Return on capital

ROCE was 15.6% for the four quarters to Sep 2026, down from 23.9% in the year to Mar 2022

Four quarters to Sep 202615.6% ROCE
15%30%Sep 22Sep 24Sep 26

ROCE average

1Y3Y5Y10Y1Y15.6%3Y18.1% to Mar5Y21.8% to Mar10Y18.2% to Mar

Profit and cash

Cash from operations was 87% of profit over five years, 89% in the year to Mar 2026

Yearly profit, cash from operations and free cash flow, ₹ crore

FY26₹127 crore operating cashProfit ₹142 crore · Free cash −₹130 crore
FY22
FY23
FY24
FY25
FY26
₹150−₹150

Profit growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y+10.9%3Y+8.1%/yr5Y+33.1%/yr to Mar10Y+21.1%/yr to Mar

Reinvestment

Capex was ₹257 crore in the year to Mar 2026, 6.3 times depreciation

FY26₹257 crore capexWork in progress ₹159 crore
FY22
FY23
FY24
FY25
FY26
0₹300

Capex growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y+192.8% to Mar3Y+29.9%/yr to Mar5YToo short10YToo short

BorrowingsInsufficient history, from Dec 2022Insufficient history, from Dec 2022

Debt ÷ equity 0.63 at 30 Sep 2026; profit covered interest 5.7x over the last four quarters

Sep 2026 balance sheet0.63 debt ÷ equityNet debt ₹636 crore
Dec 22
Mar 23
Jun 23
Sep 23
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
015x

Safety

Now3Y ago
Debt ÷ equity0.633Y ago0.48
Int. cover5.7x3Y ago5.4x

Operating health

Working capital rose from 6 to 66 days in 5 years

Year to Mar 202666 days working capital
2060Mar 22Mar 24Mar 26
Working cap.661Y−13Y+455Y+60
Debtor701Y−43Y+235Y+8
Inventory2711Y+293Y+1295Y+28

OwnershipInsufficient history, from Mar 2023Insufficient history, from Mar 2023

FIIs own 2.54%, up 0.31 points in a year. Promoters hold 69.21%

Share of the company held, %, by quarter end

Sep 2026 quarter2.54% FIIs
0%60%Sep 23Sep 24Sep 25Sep 26

Change in holding, in points

FIIs1Y+0.313Y+1.09
Promoters1Y0.003Y+0.85

Vishnu Chemicals Ltd · VISHNU · Speciality Chemicals · price as of the 18 November 2026 close, updated every trading day · results updated weekly · research updated 6 November 2026

Vishnu Chemicals share price today: ₹551.95 at the close on 18 November 2026, up 14.8% in a year. Vishnu Chemicals (VISHNU) is worth ₹3,713 crore, trades at a P/E of 24.4 and has closed between ₹480.85 and ₹722.15 over the past 52 weeks. Latest change: revenue up on a year earlier for 10 quarters in a row.

MixedBusiness trend from the last 12 quarters
₹551.95Price +14.8% in a year
24.4×P/E higher than 65% of the last 11 years
₹430 CrRevenue (Sep 2026) +7.2% on a year ago
₹36.0 CrProfit (Sep 2026) +9.1% on a year ago
14.9%Operating margin +0.4 points on a year ago
15.6%ROCE four quarters to Sep 2026
9.8%ROIC against a 12.0% cost of capital: −2.2 points

Vishnu Chemicals Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.

Biggest thing to watch: the P/E is higher than 65% of its own history, so the multiple has already done part of the work.

The price is in an uptrend that has just slipped below its 200-day average, and the P/E is higher than 65% of its own last 11 years. Over the last four quarters, results have been improving, with profit +9.1% on a year earlier, and 77% of the last 3 years' profit came in as cash. What will decide it: the next one or two quarters of results.

What is the Vishnu Chemicals share price today?

Vishnu Chemicals Ltd's share price was ₹551.95 at the close on 18 November 2026. It is in an uptrend that has just slipped below its 200-day average. That is 6.7% below its average price over the last 200 trading days.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Vishnu Chemicals Ltd is in stage 2. The phase helps read everything below.

In the last 52 weeks it traded between ₹481 and ₹722, and at that close it sat 29% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 4 weeks running.

Week by week since 2016: did it beat the NIFTY 500 over the past 13 weeks?

Ahead in 289 of 556 weeks

Week by week since 2016: did it beat the NIFTY 500 over the past 13 weeks?
Week13-week return vs NIFTY 500
26 Feb 2016no NIFTY 500 reading
4 Mar 2016no NIFTY 500 reading
11 Mar 2016no NIFTY 500 reading
18 Mar 2016no NIFTY 500 reading
23 Mar 2016no NIFTY 500 reading
1 Apr 2016no NIFTY 500 reading
8 Apr 2016no NIFTY 500 reading
13 Apr 2016no NIFTY 500 reading
22 Apr 2016no NIFTY 500 reading
29 Apr 2016no NIFTY 500 reading
6 May 2016no NIFTY 500 reading
13 May 2016no NIFTY 500 reading
20 May 2016no NIFTY 500 reading
27 May 2016+37.3%
3 Jun 2016+3.3%
10 Jun 2016+2.3%
17 Jun 2016+5.7%
24 Jun 2016−6.6%
1 Jul 2016−23.6%
8 Jul 2016−24.7%
15 Jul 2016−25.4%
22 Jul 2016−26.7%
29 Jul 2016−12.6%
5 Aug 2016−4.3%
12 Aug 2016−19.6%
19 Aug 2016−19.3%
26 Aug 2016−17.2%
2 Sep 2016−12.5%
9 Sep 2016−11.7%
16 Sep 2016−14.7%
23 Sep 2016−6.7%
30 Sep 2016+16.1%
7 Oct 2016+17.8%
14 Oct 2016+15.8%
21 Oct 2016+21.6%
30 Oct 2016+10.9%
4 Nov 2016+9.9%
11 Nov 2016+26.9%
18 Nov 2016+13.1%
25 Nov 2016+15.6%
2 Dec 2016+9.0%
9 Dec 2016+14.0%
16 Dec 2016+14.7%
23 Dec 2016+5.1%
30 Dec 2016−14.3%
6 Jan 2017−7.3%
13 Jan 2017+3.9%
20 Jan 2017−1.5%
27 Jan 2017−10.3%
3 Feb 2017−5.0%
10 Feb 2017−5.3%
17 Feb 2017+5.1%
23 Feb 2017−0.6%
3 Mar 2017+2.8%
10 Mar 2017−7.7%
17 Mar 2017−11.6%
24 Mar 2017−10.4%
31 Mar 2017+5.8%
7 Apr 2017−8.5%
13 Apr 2017−15.8%
21 Apr 2017−16.6%
28 Apr 2017−19.8%
5 May 2017−21.4%
12 May 2017−22.2%
19 May 2017−19.5%
26 May 2017−20.6%
2 Jun 2017−28.4%
9 Jun 2017−20.7%
16 Jun 2017−21.4%
23 Jun 2017−21.0%
30 Jun 2017−27.6%
7 Jul 2017−12.5%
14 Jul 2017−2.6%
21 Jul 2017−3.1%
28 Jul 2017+2.7%
4 Aug 2017+0.8%
11 Aug 2017−2.6%
18 Aug 2017−5.7%
24 Aug 2017−1.6%
1 Sep 2017+7.0%
8 Sep 2017+15.0%
15 Sep 2017+16.2%
22 Sep 2017+15.2%
29 Sep 2017+11.0%
6 Oct 2017+14.7%
13 Oct 2017+3.3%
19 Oct 2017+14.4%
27 Oct 2017+18.6%
3 Nov 2017+44.0%
10 Nov 2017+36.2%
17 Nov 2017+38.1%
24 Nov 2017+47.5%
1 Dec 2017+46.4%
8 Dec 2017+26.6%
15 Dec 2017+23.4%
22 Dec 2017+40.2%
29 Dec 2017+45.4%
5 Jan 2018+16.2%
12 Jan 2018+17.6%
19 Jan 2018+16.0%
25 Jan 2018+6.0%
2 Feb 2018−11.9%
9 Feb 2018−0.4%
16 Feb 2018−7.1%
23 Feb 2018−11.2%
1 Mar 2018−18.5%
9 Mar 2018−18.3%
16 Mar 2018−13.1%
23 Mar 2018−23.2%
28 Mar 2018−24.3%
6 Apr 2018−20.9%
13 Apr 2018−24.8%
20 Apr 2018−24.0%
27 Apr 2018−24.2%
4 May 2018−24.6%
11 May 2018−29.9%
18 May 2018−21.7%
25 May 2018−24.0%
1 Jun 2018−13.6%
8 Jun 2018−8.3%
15 Jun 2018−6.7%
22 Jun 2018−7.3%
29 Jun 2018−11.2%
6 Jul 2018−9.8%
13 Jul 2018−9.8%
20 Jul 2018−20.2%
27 Jul 2018−15.0%
3 Aug 2018−6.0%
10 Aug 2018+4.0%
17 Aug 2018−13.3%
24 Aug 2018−17.5%
31 Aug 2018−24.1%
7 Sep 2018−23.9%
14 Sep 2018−24.5%
21 Sep 2018−20.2%
28 Sep 2018−27.6%
5 Oct 2018−28.3%
12 Oct 2018−28.7%
19 Oct 2018−29.5%
26 Oct 2018−32.9%
2 Nov 2018−31.5%
9 Nov 2018−32.1%
16 Nov 2018−26.3%
22 Nov 2018−21.7%
30 Nov 2018−23.0%
7 Dec 2018−24.0%
14 Dec 2018−23.5%
21 Dec 2018−22.0%
28 Dec 2018−12.3%
4 Jan 2019−13.5%
11 Jan 2019−10.0%
18 Jan 2019−5.7%
25 Jan 2019−14.5%
1 Feb 2019−15.0%
8 Feb 2019−23.1%
15 Feb 2019−14.3%
22 Feb 2019−16.2%
1 Mar 2019−10.0%
8 Mar 2019−4.7%
15 Mar 2019−8.0%
22 Mar 2019−15.0%
29 Mar 2019−15.7%
5 Apr 2019−16.0%
12 Apr 2019−17.7%
18 Apr 2019−15.7%
26 Apr 2019+0.2%
3 May 2019−8.7%
10 May 2019+1.3%
17 May 2019−6.4%
24 May 2019−6.9%
31 May 2019−4.8%
7 Jun 2019−12.7%
14 Jun 2019−11.0%
21 Jun 2019−7.3%
28 Jun 2019−3.5%
5 Jul 2019−15.1%
12 Jul 2019−9.7%
19 Jul 2019−13.3%
26 Jul 2019−16.0%
2 Aug 2019−21.5%
9 Aug 2019−10.7%
16 Aug 2019−10.7%
23 Aug 2019−17.3%
30 Aug 2019−19.0%
6 Sep 2019−15.4%
13 Sep 2019+5.5%
20 Sep 2019−6.7%
27 Sep 2019−8.0%
4 Oct 2019+8.1%
11 Oct 2019+1.9%
18 Oct 2019+9.3%
27 Oct 2019+12.7%
1 Nov 2019+27.6%
8 Nov 2019+8.6%
15 Nov 2019+0.0%
22 Nov 2019+10.8%
29 Nov 2019+2.1%
6 Dec 2019−3.1%
13 Dec 2019−29.0%
20 Dec 2019−19.2%
27 Dec 2019−14.5%
3 Jan 2020−2.5%
10 Jan 2020−1.9%
17 Jan 2020+2.0%
24 Jan 2020−1.0%
1 Feb 2020−7.9%
7 Feb 2020−10.5%
14 Feb 2020−2.0%
20 Feb 2020−1.2%
28 Feb 2020+6.3%
6 Mar 2020+3.9%
13 Mar 2020+1.7%
20 Mar 2020+5.8%
27 Mar 2020−10.8%
3 Apr 2020−3.1%
9 Apr 2020+17.8%
17 Apr 2020+11.6%
24 Apr 2020+13.3%
30 Apr 2020+15.0%
8 May 2020+15.4%
15 May 2020+23.0%
22 May 2020+20.8%
29 May 2020+13.9%
5 Jun 2020+21.8%
12 Jun 2020+35.6%
19 Jun 2020+33.4%
26 Jun 2020+76.2%
3 Jul 2020+29.1%
10 Jul 2020−5.4%
17 Jul 2020−10.3%
24 Jul 2020−8.4%
31 Jul 2020−7.2%
7 Aug 2020+39.7%
14 Aug 2020+20.7%
21 Aug 2020+20.6%
28 Aug 2020+18.9%
4 Sep 2020+6.3%
11 Sep 2020+2.3%
18 Sep 2020+14.9%
25 Sep 2020+7.6%
1 Oct 2020+1.9%
9 Oct 2020+0.2%
16 Oct 2020+5.0%
23 Oct 2020+10.9%
30 Oct 2020+12.6%
6 Nov 2020−23.0%
14 Nov 2020−17.3%
20 Nov 2020−15.0%
27 Nov 2020−9.4%
4 Dec 2020+6.5%
11 Dec 2020+4.3%
18 Dec 2020−9.2%
24 Dec 2020−15.3%
1 Jan 2021+15.1%
8 Jan 2021+10.6%
15 Jan 2021+0.4%
22 Jan 2021−11.2%
29 Jan 2021−2.1%
5 Feb 2021−12.6%
12 Feb 2021−13.4%
19 Feb 2021−14.7%
26 Feb 2021−12.2%
5 Mar 2021−12.5%
12 Mar 2021−4.7%
19 Mar 2021+31.9%
26 Mar 2021+58.9%
1 Apr 2021+38.2%
9 Apr 2021+49.8%
16 Apr 2021+64.1%
23 Apr 2021+91.4%
30 Apr 2021+77.1%
7 May 2021+82.1%
14 May 2021+75.3%
21 May 2021+120.3%
28 May 2021+111.1%
4 Jun 2021+110.6%
11 Jun 2021+116.0%
18 Jun 2021+81.5%
25 Jun 2021+66.7%
2 Jul 2021+86.1%
9 Jul 2021+107.8%
16 Jul 2021+81.4%
23 Jul 2021+83.8%
30 Jul 2021+80.1%
6 Aug 2021+74.2%
13 Aug 2021+83.3%
20 Aug 2021+50.8%
27 Aug 2021+58.8%
3 Sep 2021+38.6%
9 Sep 2021+43.1%
17 Sep 2021+41.0%
24 Sep 2021+37.7%
1 Oct 2021+21.2%
8 Oct 2021+3.9%
14 Oct 2021+10.8%
22 Oct 2021−1.5%
29 Oct 2021+12.1%
4 Nov 2021+32.3%
12 Nov 2021+28.9%
18 Nov 2021+28.3%
26 Nov 2021+32.8%
3 Dec 2021+39.3%
10 Dec 2021+29.7%
17 Dec 2021+20.5%
24 Dec 2021+16.0%
31 Dec 2021+14.1%
7 Jan 2022+13.1%
14 Jan 2022+35.8%
21 Jan 2022+49.7%
28 Jan 2022+45.8%
4 Feb 2022+46.2%
11 Feb 2022+41.9%
18 Feb 2022+61.9%
25 Feb 2022+52.5%
4 Mar 2022+61.6%
11 Mar 2022+74.0%
17 Mar 2022+70.4%
25 Mar 2022+108.8%
1 Apr 2022+83.9%
8 Apr 2022+84.0%
13 Apr 2022+64.2%
22 Apr 2022+52.4%
29 Apr 2022+44.5%
6 May 2022+27.4%
13 May 2022+19.8%
20 May 2022+18.5%
27 May 2022+9.0%
3 Jun 2022+11.3%
10 Jun 2022+4.9%
17 Jun 2022+6.8%
24 Jun 2022−4.1%
1 Jul 2022+5.0%
8 Jul 2022−0.1%
15 Jul 2022+0.1%
22 Jul 2022−4.0%
29 Jul 2022−4.7%
5 Aug 2022−1.6%
12 Aug 2022+19.0%
19 Aug 2022+10.4%
26 Aug 2022+35.2%
2 Sep 2022+23.6%
9 Sep 2022+23.6%
16 Sep 2022+22.1%
23 Sep 2022+18.7%
30 Sep 2022+14.4%
7 Oct 2022+23.9%
14 Oct 2022+22.8%
21 Oct 2022+20.0%
28 Oct 2022+28.0%
4 Nov 2022+9.0%
11 Nov 2022−12.8%
18 Nov 2022−18.3%
25 Nov 2022−20.3%
2 Dec 2022−22.7%
9 Dec 2022−27.3%
16 Dec 2022−23.8%
23 Dec 2022−27.8%
30 Dec 2022−24.8%
6 Jan 2023−26.5%
13 Jan 2023−23.5%
20 Jan 2023−30.8%
27 Jan 2023−28.5%
3 Feb 2023−18.0%
10 Feb 2023−10.8%
17 Feb 2023−5.7%
24 Feb 2023−6.9%
3 Mar 2023−13.4%
10 Mar 2023−5.5%
17 Mar 2023−3.2%
24 Mar 2023−3.6%
31 Mar 2023−4.3%
6 Apr 2023+3.9%
13 Apr 2023−3.0%
21 Apr 2023+12.1%
28 Apr 2023+7.3%
5 May 2023+8.5%
12 May 2023+11.4%
19 May 2023+6.0%
26 May 2023+5.7%
2 Jun 2023+26.3%
9 Jun 2023+30.7%
16 Jun 2023+24.2%
23 Jun 2023+18.3%
30 Jun 2023+19.3%
7 Jul 2023+3.6%
14 Jul 2023+10.3%
21 Jul 2023+5.7%
28 Jul 2023+13.5%
4 Aug 2023+3.5%
11 Aug 2023+2.2%
18 Aug 2023−3.5%
25 Aug 2023−8.5%
1 Sep 2023−9.6%
8 Sep 2023−10.5%
15 Sep 2023−15.2%
22 Sep 2023−10.5%
29 Sep 2023−11.8%
6 Oct 2023−6.7%
13 Oct 2023−8.6%
20 Oct 2023−5.8%
27 Oct 2023−12.3%
3 Nov 2023−8.5%
12 Nov 2023−7.2%
17 Nov 2023−5.9%
24 Nov 2023−3.4%
1 Dec 2023−10.4%
8 Dec 2023−21.6%
15 Dec 2023−12.8%
22 Dec 2023−6.1%
29 Dec 2023−5.5%
5 Jan 2024−9.9%
12 Jan 2024−12.9%
20 Jan 2024−14.8%
25 Jan 2024−17.5%
2 Feb 2024−17.9%
9 Feb 2024−15.8%
16 Feb 2024−16.8%
23 Feb 2024−17.3%
2 Mar 2024−16.9%
7 Mar 2024−17.9%
15 Mar 2024−21.7%
22 Mar 2024−16.7%
28 Mar 2024−14.7%
5 Apr 2024−8.3%
12 Apr 2024−12.5%
19 Apr 2024−13.4%
26 Apr 2024−11.2%
3 May 2024−10.6%
10 May 2024−11.7%
18 May 2024−3.5%
24 May 2024−5.5%
31 May 2024+1.0%
7 Jun 2024+17.3%
14 Jun 2024+34.7%
21 Jun 2024+29.8%
28 Jun 2024+35.8%
5 Jul 2024+28.4%
12 Jul 2024+29.3%
19 Jul 2024+27.2%
26 Jul 2024+33.9%
2 Aug 2024+34.8%
9 Aug 2024+33.7%
16 Aug 2024+31.8%
23 Aug 2024+30.1%
30 Aug 2024+14.9%
6 Sep 2024+5.0%
13 Sep 2024−8.0%
20 Sep 2024−15.9%
27 Sep 2024−21.8%
4 Oct 2024−12.4%
11 Oct 2024−7.0%
18 Oct 2024+6.1%
25 Oct 2024+12.3%
1 Nov 2024+17.0%
8 Nov 2024+26.4%
14 Nov 2024+4.1%
22 Nov 2024−2.2%
29 Nov 2024+3.6%
6 Dec 2024+3.9%
13 Dec 2024+5.7%
20 Dec 2024+5.8%
27 Dec 2024+7.6%
3 Jan 2025−0.4%
10 Jan 2025−2.2%
17 Jan 2025−4.8%
24 Jan 2025−7.1%
1 Feb 2025−12.5%
7 Feb 2025−8.6%
14 Feb 2025+7.4%
21 Feb 2025+18.0%
28 Feb 2025+12.1%
7 Mar 2025+18.4%
13 Mar 2025+19.9%
21 Mar 2025+21.2%
28 Mar 2025+17.7%
4 Apr 2025+13.0%
11 Apr 2025+17.6%
17 Apr 2025+6.8%
25 Apr 2025−2.5%
2 May 2025−0.9%
9 May 2025−4.9%
16 May 2025−7.5%
23 May 2025+0.9%
30 May 2025+22.3%
6 Jun 2025+5.9%
13 Jun 2025+14.0%
20 Jun 2025+11.9%
27 Jun 2025+6.0%
4 Jul 2025+8.9%
11 Jul 2025+6.3%
18 Jul 2025+10.2%
25 Jul 2025+10.3%
1 Aug 2025+24.2%
8 Aug 2025+5.1%
14 Aug 2025+5.5%
22 Aug 2025+4.2%
29 Aug 2025−8.2%
5 Sep 2025−6.5%
12 Sep 2025−11.6%
19 Sep 2025−10.4%
26 Sep 2025−7.5%
3 Oct 2025−3.3%
10 Oct 2025−2.9%
17 Oct 2025−7.7%
24 Oct 2025−4.8%
31 Oct 2025−9.1%
7 Nov 2025−0.9%
14 Nov 2025−2.0%
21 Nov 2025−10.7%
28 Nov 2025+0.4%
5 Dec 2025−0.9%
12 Dec 2025−2.1%
19 Dec 2025+3.7%
26 Dec 2025+12.5%
2 Jan 2026+11.2%
9 Jan 2026+6.3%
16 Jan 2026+11.0%
23 Jan 2026+7.9%
1 Feb 2026−0.4%
6 Feb 2026+3.6%
13 Feb 2026+6.6%
20 Feb 2026+8.2%
27 Feb 2026−1.5%
6 Mar 2026+3.6%
13 Mar 2026+12.2%
20 Mar 2026+8.5%
27 Mar 2026+1.2%
2 Apr 2026+3.7%
10 Apr 2026+3.7%
17 Apr 2026+14.6%
24 Apr 2026+15.2%
30 Apr 2026+20.5%
8 May 2026+18.5%
15 May 2026+14.6%
22 May 2026+20.1%
29 May 2026+17.6%
4 Jun 2026+25.3%
5 Jun 2026+13.7%
9 Jun 2026+9.8%
10 Jun 2026+9.5%
12 Jun 2026+8.4%
17 Jun 2026+13.4%
19 Jun 2026+2.2%
24 Jun 2026+3.6%
25 Jun 2026+0.5%
1 Jul 2026+0.1%
3 Jul 2026+5.2%
10 Jul 2026−3.5%
17 Jul 2026+1.6%
24 Jul 2026+1.8%
31 Jul 2026−2.8%
7 Aug 2026−6.2%
14 Aug 2026+0.4%
21 Aug 2026+2.5%
28 Aug 2026+6.6%
4 Sep 2026+16.3%
11 Sep 2026+17.3%
18 Sep 2026+19.9%
25 Sep 2026+18.5%
28 Sep 2026+14.4%
1 Oct 2026+16.6%
9 Oct 2026+14.4%
16 Oct 2026+4.2%
23 Oct 2026+1.0%
30 Oct 2026+0.1%
6 Nov 2026−8.8%
8 Nov 2026−9.6%
13 Nov 2026−16.6%
18 Nov 2026−23.4%
Each bar is one week, from 2016 to now (556 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the NIFTY 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 11 years the share price moved +1,566% while the NIFTY 500 moved +306%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What changed at Vishnu Chemicals this quarter?

Two changes stood out: revenue up on a year earlier for 10 quarters in a row and foreign funds (FIIs) raised their stake for 3 quarters in a row.

  1. Revenue up on a year earlier for 10 quarters in a row

    In the September 2026 quarter revenue was ₹430 crore, +7.2% on a year earlier.

    Why: Revenue rose because the company shifted its chromium product mix to oxide and acid, with European orders and domestic demand helping.

    Next results: check whether base chrome sales lost to high shipping costs return in Q4.

    From the earnings call on 6 Nov 2026.

  2. Foreign funds (FIIs) raised their stake for 3 quarters in a row

    From 2.2% to 2.5% of the company by the September 2026 quarter.

What are Vishnu Chemicals' latest quarterly results?

For July to September 2026 (the quarter ended 30 September 2026), Vishnu Chemicals reported revenue of ₹430 crore, up 7.2% from ₹401 crore a year earlier, and a profit of ₹36.0 crore, up 9.1% from ₹33.0 crore.

Vishnu Chemicals results: July to September 2026 against a year earlier

Vishnu Chemicals results: July to September 2026 against a year earlier
MeasureJuly to September 2026July to September 2025Change
Revenue₹430 crore₹401 crore+7.2%
Profit₹36.0 crore₹33.0 crore+9.1%
Earnings per share₹5.28₹4.88+8.2%
Operating margin14.9%14.5%+0.4 points

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Vishnu Chemicals' management discussed these results on a call held on 6 November 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

What is the Vishnu Chemicals share price history?

Vishnu Chemicals closed at ₹551.95 on 18 November 2026, up 14.8% from ₹480.85 a year earlier (21 November 2025) and up 224.1% over five years. Its highest weekly close since February 2016 was ₹722.15 on 18 September 2026.

Vishnu Chemicals share price: then and now

Vishnu Chemicals share price: then and now
WhenCloseChange to 18 Nov 2026
1 week ago · 11 Nov 2026₹556.20−0.8%
1 month ago · 19 Oct 2026₹615.60−10.3%
6 months ago · 15 May 2026₹573.00−3.7%
1 year ago · 21 Nov 2025₹480.85+14.8%
3 years ago · 17 Nov 2023₹314.95+75.3%
5 years ago · 18 Nov 2021₹170.28+224.1%
10 years ago · 18 Nov 2016₹49.44+1,016.4%
Earliest weekly close in our records · 26 Feb 2016₹33.13+1,566.0%
Highest weekly close since February 2016, also the 52-week high · 18 Sep 2026₹722.15−23.6%
Lowest weekly close since February 2016 · 27 Mar 2020₹13.37+4,028.3%
52-week low (weekly close) · 21 Nov 2025₹480.85+14.8%

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 18 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

569 weekly closes from 26 February 2016 to 18 November 2026.

What is the latest news on Vishnu Chemicals?

18 Nov 2026: Vishnu Chemicals closed at ₹551.95, down 0.8% on the week and down 10.3% on the month. 6 Nov 2026: Vishnu Chemicals held its results call for July to September 2026. Management guided: DMSO operations from April to June 2027 aiming for 50-60% operating level in first year with short stabilisation.

Earlier

  • Results for July to September 2026: Revenue up 7.2% and profit up 9.1% on a year earlier.
  • 21 Aug 2026: ex-date for a dividend of ₹0.30 a share.

What dividend does Vishnu Chemicals pay?

Vishnu Chemicals paid ₹0.30 a share in regular dividends in the 12 months to 18 November 2026 (1 payment), a yield of 0.05% at the ₹551.95 close on 18 November 2026. The last was a dividend of ₹0.30 a share, ex-date 21 August 2026.

Vishnu Chemicals dividends since 1 April 2021

Vishnu Chemicals dividends since 1 April 2021
Ex-dateDividend per shareTypeRecord date
21 Aug 2026Dividend₹0.30Dividendsame day
8 Aug 2025Dividend₹0.30Dividendsame day
20 Sep 2024Dividend₹0.30Dividend—
4 Aug 2023Dividend₹0.40Dividend—
7 Jul 2022Dividend₹2Dividend—
1 Jul 2021Dividend₹1Dividend2 Jul 2021

Amounts as the company declared them on the exchange. A dividend goes to whoever owns the shares before the ex-date.

5 of 5Of the last 5 financial years, years with an exchange dividend record

Yes. Vishnu Chemicals Ltd paid out 1% of its profit as dividends in FY26, and it paid a dividend in 11 of its last 13 reported years.

From the exchange corporate-actions record, read 18 November 2026.

What did Vishnu Chemicals management say on the latest results call?

On the call for July to September 2026, held on 6 November 2026, Vishnu Chemicals' management guided: DMSO operations from April to June 2027 aiming for 50-60% operating level in first year with short stabilisation.

“During the quarter gone by, our shipping and forwarding expense increased to 8.8% of operating revenue compared to 5.9% in the preceding quarter of this financial year.”Siddarth Cherukuri, on the call for July to September 2026

What management guided

  • Strontium optimum 70% utilisation next year on import substitution with approvals converting.
  • South Africa ore shipments to India from January to March 2027 with significant contribution next year.
  • Chromium-metal joint venture aiming for above 20% operating profit with India Phase-1 from January to March 2028.
  • Remaining capital spending ₹300-330Cr over next year of ₹524 crore total with ₹190 crore spent; DMSO ₹250 crore and oxide ₹220 crore; peak debt ₹800-820Cr versus ₹717 crore now.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for July to September 2026, 6 November 2026.

What to watch in Vishnu Chemicals' next results?

When Vishnu Chemicals reports October to December 2026, these are the 3 checks that show whether the story is still on course. First: Parwada restart and Q3 sales impact vs no-loss claim - verify resumption intimation and output.

Management raised each of these on the latest results call.

  • Parwada restart and Q3 sales impact vs no-loss claim - verify resumption intimation and output.
  • Westbound freight cost and base-chrome volumes - check normalisation from spike with volume return.
  • South Africa beneficiation output and first India ore transfer - track commissioning progress and shipment.

Which stock lists is Vishnu Chemicals on?

Vishnu Chemicals is not on any of our India lists this week.

Is Vishnu Chemicals profitable?

Vishnu Chemicals Ltd earned ₹36.0 Cr of net profit in the Sep 2026 quarter, +9.1% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹142 Cr. Over 10 years profit has grown 21.1% a year on average. The same quarter a year earlier earned ₹33.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The Sep 2026 quarter's profit is 8.4% of that quarter's revenue.

For the full year, FY26 profit was ₹142 Cr (+11.8% on the year before).

Why profit moved: revenue changed +7.2% on a year earlier and the margin moved +0.4 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +11.1% and revenue +14.3%. Profit is growing slower than sales: rising costs are taking part of the growth.

How much revenue does Vishnu Chemicals make, and is it growing?

Vishnu Chemicals Ltd reported ₹430 Cr of revenue in the Sep 2026 quarter, +7.2% on the same quarter a year earlier. That is the 10th quarter in a row with growth on the year before. Over 10 years it has grown 12.9% a year on average. The last full year, FY26, came in at ₹1,610 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹1,724 Cr.

FY26 revenue was ₹1,610 Cr, +11.3% on the year before.

Recent pace: the last four quarters grew +14.3% on average, against 12.9% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +14.0%, against +15.7% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +10.9%, against +22.5% a year (rolling over).

How much of every ₹100 of sales does Vishnu Chemicals keep?

Vishnu Chemicals Ltd's operating margin was 14.9% in the Sep 2026 quarter, 0.4 percentage points higher than the same quarter a year ago. Across 13 years it has been between 11.6% and 18.9%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +0.4 percentage points on the year while gross margin changed +8.2 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

Is Vishnu Chemicals' profit turning into cash?

Over the last 3 years, 77% of Vishnu Chemicals Ltd's reported profit came in as cash from its operations, so most of the profit is real cash. In FY26 it brought in ₹127 Cr of operating cash against ₹142 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹257 Cr of spending on assets, free cash was −₹130 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 77% of profit came in as cash: the cash cycle got 18 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: less of the profit turns into cash than it should, and the cash cycle is 18 days longer. The next section looks at where the cash is stuck.

Where does Vishnu Chemicals' cash go?

Vishnu Chemicals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 149 days in FY26, up from 131 days in FY21. It spent ₹465 Cr on assets over the last 3 years. Customers take 70 days to pay, and stock sits for 271 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹1,610 Cr, each day of that cycle ties up about ₹4.4 Cr, so roughly ₹657 Cr is tied up in the business at any time.

FY26: customers took 70 days to pay and stock sat for 271 days, about 8.9 months of sales sitting as stock, for a full cycle of 149 days, longer than FY21's 131.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 271 days. Customers pay about 70 days after that. Suppliers are paid at 193 days. Together that makes the 149-day cycle.

Spending on assets: ₹465 Cr over the last 3 years, against ₹113 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹159 Cr (FY26): assets paid for that are not earning yet.

In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit.

What is Vishnu Chemicals' P/E ratio, and how does it compare with its own history?

Vishnu Chemicals Ltd's P/E is 24.4×, in the middle of its own history: higher than 65% of past readings. Its usual P/E (the middle reading) is 17.4×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

24.4×P/E · higher than 65% of its last 11 years
n/mPEG · cannot be worked out, because 3-year earnings growth is not available

Why the multiple is where it is: over the past year earnings per share moved +9.4% while the price moved +14.8%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 5 years the price moved +26.5% a year; about +25.9% a year came from earnings growth and about +0.6 percentage points from the multiple (roughly no change); over 10 years the price moved +27.3% a year; about +20.3% a year came from earnings growth and about +7.0 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Is the Vishnu Chemicals business getting better or worse?

Vishnu Chemicals Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE falling at 15.6% (four quarters to Sep 2026); each line tells part of the story. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Steady highRevenue growth · latest (Sep 2026) +14.0%, range −12.8% to +19.3%
Turning downProfit growth · latest (Sep 2026) +10.9%, range −25.5% to +35.3%
FlatEPS growth · latest (Sep 2026) +9.4%, range −30.7% to +33.2%
Turning downROCE · latest (four quarters to Sep 2026) 15.6%, range 15.6% to 24.5%

Why it matters: when the lines disagree, each line above matters more than any single label.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+11.3%+5.0%+18.8%+12.9%
Profit+11.8%+1.2%+33.1%+21.1%
EPS+12.3%−2.6%+29.6%+19.5%
Share price+14.8%+20.6%+26.5%+27.3%
+7.2%Revenue growth (Sep 2026) · latest quarter against a year ago
+9.1%Profit growth (Sep 2026) · latest quarter against a year ago
12.9%Revenue, 10 years · yearly growth over the long run

How much does Vishnu Chemicals earn on its capital?

Vishnu Chemicals Ltd earned a ROCE of 16% in FY26. That is up from a low of 12% in FY21. Its return on capital used (ROIC) is 2.2 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

It comes from a 8.8% net margin and 0.77× asset turnover (sales divided by assets).

Why the return is what it is (FY26): a 8.8% net margin × 0.77× asset turnover × 1.95× leverage (assets divided by equity) ≈ 13.2% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 9.8% − 12.0% = −2.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

Does Vishnu Chemicals have too much debt?

Vishnu Chemicals Ltd has total debt of ₹718 Cr against shareholder equity of ₹1,146 Cr as of Sep 2026, so its debt is 0.63× its equity. Year by year, that ratio went from 1.32 in FY22 to 0.49 in FY26. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

What is the Vishnu Chemicals shareholding pattern?

Foreign institutions raised their stake in Vishnu Chemicals Ltd by 1.6 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 2.5% of the company. Promoters moved +0.8 points over the same period, to 69.2%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Foreign institutions: +1.6 points over 8 quarters, to 2.5%; Promoters: +0.8 points over 8 quarters, to 69.2%; Domestic institutions: −0.7 points over 8 quarters, to 5.8%.

Why the owners changed: foreign institutions drove it (+1.6 points), together with promoters (+0.8 points). They raised their stake step by step.

How far is Vishnu Chemicals from balance-sheet trouble?

For Vishnu Chemicals Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

How does Vishnu Chemicals rank in its industry?

37.6 out of 100, rank 29 of 30 in Speciality Chemicals, with 90% of the evidence available.

Vishnu Chemicals Ltd scores 37.6 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 29. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 13.4 + 13.3 + 8.1 + 2.8 = 37.6. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Vishnu Chemicals compared with?

Vishnu Chemicals ranks 29 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 37.6 out of 100.

  1. 1Panama Petrochem LtdPANAMAPET · losing its lead · Most evidence points up · 90% evidence77.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 33.5/35 · Revenue 75% · Profit 100% · Operating margin change 8 points · 100% evidenceCapital efficiency 17.2/25 · ROCE 19.2% (year to Mar 2026) · Operating margin 17.2% · 100% evidenceValuation 14.6/20 · P/E 3.8× · PEG — · 50% evidenceRelative strength 11.9/20 · Strength vs its industry (price vs its 52-week average, weekly) 12.1% · Strength vs NIFTY 500 (same reading) 15.8% · 1 year 39.7% · 100% evidence · 8 of 12 weeks aheadExact sum: 33.5 + 17.2 + 14.6 + 11.9 = 77.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2Galaxy Surfactants LtdGALAXYSURF · losing its lead · Most evidence points up · 85% evidence67.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 28.0/35 · Revenue 30.2% · Profit 42.3% · Operating margin change 2 points · 100% evidenceCapital efficiency 11.9/25 · ROCE 13.5% (year to Mar 2026) · Operating margin 10.5% · 100% evidenceValuation 16.2/20 · P/E 19.3× · PEG 1.14 · 100% evidenceRelative strength 11.3/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) 6.9% · 1 year 7.5% · 25% evidence · 11 of 12 weeks aheadExact sum: 28 + 11.9 + 16.2 + 11.3 = 67.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  3. 3Black Rose Industries LtdBLACKROSE · quiet · Most evidence points up · 75% evidence66.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 27.4/35 · Revenue 13% · Profit 65% · Operating margin change 5 points · 100% evidenceCapital efficiency 14.8/25 · ROCE 18.7% (year to Mar 2026) · Operating margin 13.6% · 100% evidenceValuation 14.4/20 · P/E 15.3× · PEG — · 50% evidenceRelative strength 9.8/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) 0.6% · 1 year — · 25% evidence · 6 of 12 weeks aheadExact sum: 27.4 + 14.8 + 14.4 + 9.8 = 66.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4Yasho Industries LtdYASHO · losing its lead · Evidence leans up · 68% evidence64.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 30.4/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidenceCapital efficiency 12.6/25 · ROCE 8.9% (year to Mar 2026) · Operating margin 21% · 100% evidenceValuation 9.1/20 · P/E 52.1× · PEG — · 15% evidenceRelative strength 12.2/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) 44% · 1 year 126.5% · 25% evidence · 9 of 12 weeks aheadExact sum: 30.4 + 12.6 + 9.1 + 12.2 = 64.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5Fineotex Chemical LtdFCL · leader · Evidence leans up · 100% evidence61.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.8/35 · Revenue 100% · Profit 68.7% · Operating margin change -8 points · 100% evidenceCapital efficiency 13.8/25 · ROCE 18.3% (year to Mar 2026) · Operating margin 15.5% · 100% evidenceValuation 9.1/20 · P/E 39.9× · PEG 1.13 · 100% evidenceRelative strength 18.2/20 · Strength vs its industry (price vs its 52-week average, weekly) 42.8% · Strength vs NIFTY 500 (same reading) 45.9% · 1 year 81.3% · 100% evidence · 12 of 12 weeks aheadExact sum: 20.8 + 13.8 + 9.1 + 18.2 = 61.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Tatva Chintan Pharma Chem LtdTATVA · losing its lead · Evidence leans up · 93% evidence61.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 28.9/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidenceCapital efficiency 8.8/25 · ROCE 7.2% (year to Mar 2026) · Operating margin 18.9% · 100% evidenceValuation 10.3/20 · P/E 61.3× · PEG 1.23 · 65% evidenceRelative strength 13.1/20 · Strength vs its industry (price vs its 52-week average, weekly) 11.4% · Strength vs NIFTY 500 (same reading) 15.7% · 1 year 13.8% · 100% evidence · 8 of 12 weeks aheadExact sum: 28.9 + 8.8 + 10.3 + 13.1 = 61.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7Privi Speciality Chemicals LtdPRIVISCL · quiet · Evidence leans up · 82% evidence60.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.6/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidenceCapital efficiency 18.6/25 · ROCE 22.3% (year to Mar 2026) · Operating margin 26.3% · 76% evidenceValuation 9.8/20 · P/E 36× · PEG — · 50% evidenceRelative strength 8.0/20 · Strength vs its industry (price vs its 52-week average, weekly) -3.5% · Strength vs NIFTY 500 (same reading) 0.9% · 1 year 9.4% · 100% evidence · 0 of 12 weeks aheadExact sum: 23.6 + 18.6 + 9.8 + 8 = 60 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8Vikram Thermo (India) Ltdbreaking out · Evidence leans up · 72% evidence59.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change -4 points · 95% evidenceCapital efficiency 21.2/25 · ROCE 36.2% (year to Mar 2026) · Operating margin 40.9% · 95% evidenceValuation 7.4/20 · P/E 21.7× · PEG — · 50% evidenceRelative strength 12.0/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) 39.3% · 1 year — · 25% evidence · 12 of 12 weeks aheadExact sum: 18.8 + 21.2 + 7.4 + 12 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  9. 9Aarti Industries LtdAARTIIND · losing its lead · Evidence leans up · 100% evidence59.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.4/35 · Revenue 39.8% · Profit 100% · Operating margin change -3 points · 100% evidenceCapital efficiency 9.8/25 · ROCE 6.9% (year to Mar 2026) · Operating margin 11.2% · 100% evidenceValuation 13.7/20 · P/E 28.3× · PEG 0.93 · 100% evidenceRelative strength 9.1/20 · Strength vs its industry (price vs its 52-week average, weekly) -0.6% · Strength vs NIFTY 500 (same reading) 4% · 1 year 20.2% · 100% evidence · 4 of 12 weeks aheadExact sum: 26.4 + 9.8 + 13.7 + 9.1 = 59 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10Chemcon Speciality Chemicals LtdCHEMCON · breaking out · Evidence leans up · 75% evidence55.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.1/35 · Revenue 22.3% · Profit 20.2% · Operating margin change 4.1 points · 100% evidenceCapital efficiency 8.8/25 · ROCE 6.3% (year to Mar 2026) · Operating margin 16.9% · 100% evidenceValuation 11.3/20 · P/E 23.4× · PEG — · 50% evidenceRelative strength 11.2/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) 5.1% · 1 year -12.6% · 25% evidence · 9 of 12 weeks aheadExact sum: 24.1 + 8.8 + 11.3 + 11.2 = 55.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  11. 11Aether Industries LtdAETHER · losing its lead · Evidence leans up · 100% evidence53.8out of 100GrowthCapitalValuationRelative
  12. 12Kronox Lab Sciences LtdKRONOX · breaking out · Evidence leans up · 68% evidence53.6out of 100GrowthCapitalValuationRelative
  13. 13Paushak LtdPAUSHAKLTD · losing its lead · Evidence leans up · 75% evidence51.5out of 100GrowthCapitalValuationRelative
  14. 14Alkyl Amines Chemicals LtdALKYLAMINE · quiet · Evidence leans up · 100% evidence51.0out of 100GrowthCapitalValuationRelative
  15. 15Neogen Chemicals LtdNEOGEN · leader · Evidence leans up · 100% evidence50.8out of 100GrowthCapitalValuationRelative
  16. 16Platinum Industries LtdPLATIND · turning · Evidence leans down · 75% evidence49.9out of 100GrowthCapitalValuationRelative
  17. 17Pidilite Industries LtdPIDILITIND · quiet · Evidence leans down · 100% evidence49.3out of 100GrowthCapitalValuationRelative
  18. 18Anupam Rasayan India LtdANURAS · turning · Evidence leans down · 82% evidence48.9out of 100GrowthCapitalValuationRelative
  19. 19Sunshield Chemicals LtdSUNSHIEL · quiet · Evidence leans down · 75% evidence48.2out of 100GrowthCapitalValuationRelative
  20. 20Grauer & Weil (India) LtdGRAUWEIL · breaking out · Evidence leans down · 90% evidence46.1out of 100GrowthCapitalValuationRelative
  21. 21Amines & Plasticizers LtdAMNPLST · quiet · Evidence leans down · 75% evidence45.7out of 100GrowthCapitalValuationRelative
  22. 22DIC India LtdDICIND · Evidence leans down · 70% evidence45.3out of 100GrowthCapitalValuationRelative
  23. 23DMCC Speciality Chemicals LtdDMCC · quiet · Evidence leans down · 83% evidence43.4out of 100GrowthCapitalValuationRelative
  24. 24Clean Science & Technology LtdCLEAN · quiet · Evidence leans down · 85% evidence43.1out of 100GrowthCapitalValuationRelative
  25. 25Vinati Organics LtdVINATIORGA · quiet · Evidence leans down · 82% evidence43.1out of 100GrowthCapitalValuationRelative
  26. 26Amal LtdAMAL · quiet · Evidence leans down · 68% evidence43.1out of 100GrowthCapitalValuationRelative
  27. 27Innovassynth Technologies (India) Ltdbreaking out · Too little evidence to rank firmly · 57% evidence40.3out of 100GrowthCapitalValuationRelative
  28. 28Transpek Industry LtdTRANSPEK · turning · Evidence leans down · 67% evidence38.6out of 100GrowthCapitalValuationRelative
  29. 29Vishnu Chemicals Ltd this pageVISHNU · losing its lead · Evidence leans down · 90% evidence37.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 13.4/35 · Revenue 14% · Profit 10.9% · Operating margin change 0 points · 100% evidenceCapital efficiency 13.3/25 · ROCE 16.4% (year to Mar 2026) · Operating margin 14.9% · 100% evidenceValuation 8.1/20 · P/E 24.4× · PEG — · 50% evidenceRelative strength 2.8/20 · Strength vs its industry (price vs its 52-week average, weekly) -11.4% · Strength vs NIFTY 500 (same reading) -7.6% · 1 year 14.8% · 100% evidence · 8 of 12 weeks aheadExact sum: 13.4 + 13.3 + 8.1 + 2.8 = 37.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  30. 30Thirumalai Chemicals LtdTIRUMALCHM · quiet · Most evidence points down · 71% evidence34.0out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Speciality Chemicals, all 30 compared on one page.

Which companies are close to Vishnu Chemicals in size?

Vishnu Chemicals is the 14th largest of 30 Speciality Chemicals companies on Sector Alpha by market value (at the 18 November 2026 close). Just above it: Fineotex Chemical, Yasho Industries and Tatva Chintan Pharma Chem. Just below it: Grauer & Weil (India), Panama Petrochem and Innovassynth Technologies (India).

Speciality Chemicals companies close in size

  1. Fineotex Chemical Ltd ₹5,197 crore
  2. Yasho Industries Ltd ₹4,510 crore
  3. Tatva Chintan Pharma Chem Ltd ₹3,857 crore
  4. Vishnu Chemicals Ltd ₹3,715 crore
  5. Grauer & Weil (India) Ltd ₹3,419 crore
  6. Panama Petrochem Ltd ₹2,564 crore
  7. Innovassynth Technologies (India) Ltd ₹1,531 crore

All 30 Speciality Chemicals companies, largest first

Companies close in size in other industries

  1. Yash Highvoltage Ltd ₹3,742 crore · Electric Equipment - General
  2. Caliber Mining and Logistics Ltd ₹3,723 crore · Mining/Minerals
  3. Vishnu Chemicals Ltd ₹3,715 crore
  4. Dalmia Bharat Sugar & Industries Ltd ₹3,710 crore · Sugar
  5. Sterling & Wilson Renewable Energy Ltd ₹3,701 crore · Solar EPC

What else do people ask about Vishnu Chemicals?

What is Vishnu Chemicals's share price today?

Vishnu Chemicals Ltd's share price is ₹551.95, +14.8% over the past year. The whole company is worth ₹3,713 Cr on the market.

In the last 52 weeks it traded between ₹481 to ₹722; today it is 29% of the way up from the low, 6.7% below its 200-day average (as of 18 November 2026).

What were Vishnu Chemicals's latest quarterly results?

Vishnu Chemicals Ltd reported revenue of ₹430 Cr and net profit of ₹36.0 Cr for the Sep 2026 quarter. Revenue rose 7.2% and profit rose 9.1% compared with a year earlier. Earnings per share were ₹5.28.

The operating margin was 14.9%, 0.4 percentage points higher than a year earlier (as of 18 November 2026).

What is Vishnu Chemicals's market cap?

Vishnu Chemicals Ltd's market capitalisation is ₹3,713 Cr at a share price of ₹551.95. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 18 November 2026).

How is Vishnu Chemicals performing?

Vishnu Chemicals Ltd's share price is in an uptrend that has just slipped below its 200-day average. In its latest quarter, revenue rose 7.2% and profit rose 9.1% compared with a year earlier.

Over the past 13 weeks it has done worse than the NIFTY 500, for 4 weeks running (as of 18 November 2026).

Is Vishnu Chemicals in an uptrend?

Yes, the price has been rising for 93 weeks (stage 2 of 4), 6.7% below its 200-day average, and 29% of the way up its 52-week range. A share price tends to move through four phases: moving sideways, rising, stalling and falling (as of 18 November 2026).

Will Vishnu Chemicals's share price go up?

This page does not forecast Vishnu Chemicals Ltd's share price. What it shows instead: the share price is ₹551.95, and it has been rising for 93 weeks. Its P/E of 24.4× is higher than 65% of its own last 11 years (as of 18 November 2026).

Where is Vishnu Chemicals in its business cycle?

Vishnu Chemicals Ltd's FY26 operating margin was 15.7%, against a 13-year range of 11.6% to 18.9%. The latest quarter was 14.9%, the middle of its own range, neither a peak nor a low.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 18 November 2026).

What could break the Vishnu Chemicals story?

Biggest thing to watch: the P/E is higher than 65% of its own history, so the multiple has already done part of the work.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 18 November 2026).

Is Vishnu Chemicals a stock worth studying right now?

What the numbers show: Vishnu Chemicals Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 18 November 2026).

Is there a Vishnu Chemicals share price forecast for 2026?

What management itself guided: DMSO operations from April to June 2027 aiming for 50-60% operating level in first year with short stabilisation.

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 18 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.